Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Psychostimulants 

Psychostimulants
Chapter:
Psychostimulants
Author(s):

Leslie L. Iversen

, Susan D. Iversen

, Floyd E. Bloom

, and Robert H. Roth

DOI:
10.1093/med/9780195380538.003.0560
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 05 June 2020

This chapter focuses on the three most common illicit psychostimulants, as opposed to the legal compounds caffeine (coffee and tea) (see Chapter 16) and nicotine (Chapter 26). Cocaine, amphetamines, and Ecstasy share many common features with regard to their mode of action and psychopharmacology. All three act by stimulating monoamine mechanisms in brain indirectly by promoting the release of these neurotransmitters (amphetamines and Ecstasy) or by slowing their inactivation through reuptake mechanisms (cocaine). Amphetamines and Ecstasy also share a common molecular structure—a benzene ring with a phenylethylamine side chain.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.